Dishman Group

Dishman is the global outsourcing partner for the pharmaceutical industry offering a portfolio of development, scale-up and manufacturing services.

The products and services offered span customers’ needs from chemical development to commercial manufacture and supply of active pharmaceutical ingredients.

Dishman has a relationship driven business model that improves its customers businesses by providing a range of solutions at locations in Europe, China and India. Our offer delivers the best of both worlds:

• western expertise in speed, flexibility, innovation and rapid material provision
• new world expertise in process optimisation, robust large scale processes and secure economic commercial supply.

Products and Services

NCEs

• Large dedicated R&D centre with multiple shift R&D operations (India)
• Development services, kilo supply, cGMP pilot production, full scale cGMP manufacture (India, China)
• 12 multi-purpose and dedicated production facilities for APIs, intermediates (India, China)
• 1125 m³ dedicated API manufacturing capacity (India, China)
• Broad range of technical skills and capabilities encompassing all routine chemistries and a wide variety of sophisticated modern technologies (India, China)

Softgel CRAMs

• With 1 pilot Softgel facility and 2 dedicated encapsulation lines, we have established an in-house combined production capacity of 800 million softgel capsules a year.
• The total built-up area of the facility is approximately 30,000 sq. ft.
• The facility is controlled by Schneider Building Management System (BMS).
• Dishman has largely indulged in developing sophisticated infrastructure which enables the production of various novel dosage formulations in soft gelatine capsules.

Highly Potent API Services

• Manufacture of quality Active Pharmaceutical Ingredients (APIs) and intermediates
• Expertise in process optimization and large scale cGMP production
• Substantial regulatory expertise and support
• Development of DMFs, CTDs for advanced intermediates and final APIs
• Strong technology offering to both the generic and ethical
• Pharmaceutical industry